EIDX
Eidos Therapeutics, Inc. Common Stock
EIDX
EIDX
Delisted
EIDX was delisted on the 25th of January, 2021.
60 hedge funds and large institutions have $182M invested in Eidos Therapeutics, Inc. Common Stock in 2018 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 17 increasing their positions, 16 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
6% more repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 16
Holders
60
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$5.8M | |
| 2 | +$2.83M | |
| 3 | +$2M | |
| 4 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$1.93M |
| 5 |
Fiera Capital (Canada)
Montreal,
Quebec, Canada
|
+$1.81M |
Top Sellers
| 1 | -$4.2M | |
| 2 | -$2.25M | |
| 3 | -$1.28M | |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
-$766K |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$618K |